These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


513 related items for PubMed ID: 6324995

  • 21. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries.
    Merke J, Milde P, Lewicka S, Hügel U, Klaus G, Mangelsdorf DJ, Haussler MR, Rauterberg EW, Ritz E.
    J Clin Invest; 1989 Jun; 83(6):1903-15. PubMed ID: 2542376
    [Abstract] [Full Text] [Related]

  • 22. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
    Greising DM, Schwartz Z, Posner GH, Sylvia VL, Dean DD, Boyan BD.
    J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).
    Liel Y, Kraus S, Levy J, Shany S.
    Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250
    [Abstract] [Full Text] [Related]

  • 25. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
    Reinhardt TA, Horst RL.
    Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
    [Abstract] [Full Text] [Related]

  • 26. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
    Boyan BD, Posner GH, Greising DM, White MC, Sylvia VL, Dean DD, Schwartz Z.
    J Cell Biochem; 1997 Sep 15; 66(4):457-70. PubMed ID: 9282324
    [Abstract] [Full Text] [Related]

  • 27. Effect of 1,25-dihydroxyvitamin D3 on mouse mammary tumor (GR) cells: evidence for receptors, cellular uptake, inhibition of growth and alteration in morphology at physiologic concentrations of hormone.
    Gross M, Kost SB, Ennis B, Stumpf W, Kumar R.
    J Bone Miner Res; 1986 Oct 15; 1(5):457-67. PubMed ID: 2845731
    [Abstract] [Full Text] [Related]

  • 28. Interferon-gamma-induced IA expression in WEHI-3 cells is enhanced by the presence of 1,25-dihydroxyvitamin D3.
    Morel PA, Manolagas SC, Provvedini DM, Wegmann DR, Chiller JM.
    J Immunol; 1986 Mar 15; 136(6):2181-6. PubMed ID: 3005406
    [Abstract] [Full Text] [Related]

  • 29. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
    Frampton RJ, Suva LJ, Eisman JA, Findlay DM, Moore GE, Moseley JM, Martin TJ.
    Cancer Res; 1982 Mar 15; 42(3):1116-9. PubMed ID: 6277475
    [Abstract] [Full Text] [Related]

  • 30. 1 alpha, 25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line.
    Franceschi RT, James WM, Zerlauth G.
    J Cell Physiol; 1985 Jun 15; 123(3):401-9. PubMed ID: 2985632
    [Abstract] [Full Text] [Related]

  • 31. The E1A oncogene induces resistance to the effects of 1,25-dihydroxyvitamin D3 on inhibition of growth of mouse keratinocytes.
    Park K, Bae H, Heydemann A, Roberts AB, Dotto GP, Sporn MB, Kim SJ.
    Cancer Res; 1994 Dec 01; 54(23):6087-9. PubMed ID: 7954451
    [Abstract] [Full Text] [Related]

  • 32. Identification of the subdomain in the nuclear receptor for the hormonal form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3, vitamin D receptor, that is covalently modified by an affinity labeling reagent.
    Swamy N, Kounine M, Ray R.
    Arch Biochem Biophys; 1997 Dec 01; 348(1):91-5. PubMed ID: 9390178
    [Abstract] [Full Text] [Related]

  • 33. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D.
    Koren R, Ravid A, Liberman UA, Hochberg Z, Weisman Y, Novogrodsky A.
    J Clin Invest; 1985 Nov 01; 76(5):2012-5. PubMed ID: 2997300
    [Abstract] [Full Text] [Related]

  • 34. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep 01; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 35. Identification of a competitive binding component in vitamin D-resistant New World primate cells with a low affinity but high capacity for 1,25-dihydroxyvitamin D3.
    Gacad MA, Adams JS.
    J Bone Miner Res; 1993 Jan 01; 8(1):27-35. PubMed ID: 8381251
    [Abstract] [Full Text] [Related]

  • 36. 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture.
    Colston K, Colston MJ, Feldman D.
    Endocrinology; 1981 Mar 01; 108(3):1083-6. PubMed ID: 6257495
    [Abstract] [Full Text] [Related]

  • 37. 1 alpha,25-dihydroxyvitamin D3 inhibits cell growth and chondrogenesis of a clonal mouse EC cell line, ATDC5.
    Akiyama H, Hiraki Y, Shigeno C, Kohno H, Shukunami C, Tsuboyama T, Kasai R, Suzuki F, Konishi J, Nakamura T.
    J Bone Miner Res; 1996 Jan 01; 11(1):22-8. PubMed ID: 8770693
    [Abstract] [Full Text] [Related]

  • 38. Retinoic acid-induced changes in 1 alpha,25-dihydroxyvitamin D3 receptor levels in tumor and nontumor cells derived from rat bone.
    Petkovich PM, Heersche JN, Aubin JE, Grigoriadis AE, Jones G.
    J Natl Cancer Inst; 1987 Feb 01; 78(2):265-70. PubMed ID: 3027442
    [Abstract] [Full Text] [Related]

  • 39. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells.
    Guerrero R, de la Piedra C, Teixeiro E, Bragado R, Traba ML.
    J Rheumatol; 2004 Jan 01; 31(1):167-72. PubMed ID: 14705237
    [Abstract] [Full Text] [Related]

  • 40. Effect of 1,25-dihydroxyvitamin D3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes.
    Kanatani M, Sugimoto T, Fukase M, Chihara K.
    Biochem Biophys Res Commun; 1993 Jan 29; 190(2):529-35. PubMed ID: 8427595
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.